DOD Amyotrophic Lateral Sclerosis, Therapeutic Idea Award
DOD grant for innovative ALS research ideas that could lead to new therapies, emphasizing strong approaches over extensive preliminary data.
This grant is no longer accepting proposals
Dept. of the Army -- USAMRAA has archived this opportunity.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 6, 2025 (Pre-application) | August 27, 2025 (Full application)
Funding Amounts: Up to $840,000 total costs per award over 2 years; ~12 awards; $10.08M total program funding.
Summary: Supports innovative, high-risk/high-gain research projects for ALS drug or therapy discovery that generate preliminary data for future therapeutic development.
Key Information: Pre-application required; focus must include biomarker development relevant to therapeutic strategy.
Description
This grant opportunity, offered by the Department of Defense's Amyotrophic Lateral Sclerosis Research Program (ALSRP), seeks to support new, innovative, and high-risk/high-gain research ideas for ALS drug or therapy discovery. Projects should be hypothesis-driven and are expected to generate preliminary data that could enable future therapeutic development. The mechanism emphasizes innovation, impact, and strong scientific rationale, and requires incorporation of biomarker development relevant to the proposed therapeutic approach. Projects focusing solely on ALS pathophysiology or on biomarkers for diagnosis/prognosis without a therapeutic link are not eligible.
